Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (2): 6-10.doi: 10.6040/j.issn.1671-7554.0.2018.1459

Previous Articles    

Endocrine changes in perimenopausal women and the related diseases

ZHU Xiaoming1,2,3, XU Junbi4, HE Renke4, ZHU Shulan4, JIN Lixue4   

  1. 1. Department of Obstetrics &
    Gynecology, Womens Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China;
    2. Womens Reproductive Health Key Laboratory of Zhejiang Province, Hangzhou 310006, Zhejiang, China;
    3. Key Laboratory of Reproductive Genetics(Zhejiang University), Ministry of Education, Hangzhou 310058, Zhejiang, China;
    4. Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China
  • Published:2022-09-27

Abstract: Perimenopausal women undergo a decline of the whole bodys function, especially the ovarian aging accompanied with endocrine changes, which will induce a series of physical and mental discomforts even illnesses, and will 山 东 大 学 学 报 (医 学 版)57卷2期 -朱小明,等.围绝经期妇女内分泌变化及相关疾病 \=-affect the life and living quality in a negative way. With more knowledge of the critical changes in perimenopause, it is now realized that perimenopause is not just a simply physiological period, but an important period that need more protection and health cares. Deep understanding of the natural aging and illnesses in perimenopausal women is essential to maintain the natural physiology, guarantee the health and improve the living quality.

Key words: Perimenopause, Female, Endocrine, Diseases

CLC Number: 

  • R711.75
[1] Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging[J]. J Clin Endocrinol Metab, 2012, 97(4): 1159-1168.
[2] van den Beld AW, Kaufman JM, Zillikens MC, et al. The physiology of endocrine systems with ageing[J]. Lancet Diabetes Endocrinol, 2018, 6(8): 647-658.
[3] Randolph JF Jr, Zheng HY, Sowers MR, et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period[J]. J Clin Endocrinol Metab, 2011, 96(3): 746-754.
[4] Rosen MP, Johnstone E, McCulloch CE, et al. A characterization of the relationship of ovarian reserve markers with age[J]. Fertil Steril, 2012, 97(1): 238-243.
[5] Santoro N, Crawford SL, El Khoudary SR, et al. Menstrual cycle hormone changes in women traversing menopause: study of womens health across the nation[J]. J Clin Endocrinol Metab, 2017, 102(7): 2218-2229.
[6] Davis SR, Wahlin-Jacobsen S. Testosterone in women: the clinical significance[J]. Lancet Diabetes Endocrinol, 2015, 3(12): 980-992.
[7] Thilagam A. Mathematical modelling of decline in follicle pool during female reproductive ageing[J]. Math Med Biol, 2016, 33(1): 107-121.
[8] Chao KC, Ho CH, Shyong WY, et al. Anti-Mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese women[J]. J Chin Med Assoc, 2012, 75(2): 70-74.
[9] 杨玲, 王建荣. 不同生理阶段更年期综合征患者Kupperman评分、体内激素和内分泌代谢指标的比较[J]. 中国老年学杂志, 2015, 35(22): 6413-6414.
[10] 陈蓉, 林守清, 凌晨, 等. 绝经过渡期妇女性激素与胰岛素敏感性的改变[J]. 现代妇产科进展, 2006, 15(9): 693-696. CHEN Rong, LIN Shouqing, LING Chen, et al. The change of sex hormones and insulin sensitivity in menopause transition women[J]. Progress in Obstetrics and Gynecology, 2006, 15(9): 693-696.
[11] Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women[J]. Hum Reprod Update, 2014, 20(3): 370-385.
[12] Bremner AP, Feddema P, Leedman PJ, et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort[J]. J Clin Endocrinol Metab, 2012, 97(5): 1554-1562.
[13] Chaker L, Korevaar TI, Medici M, et al. Thyroid function characteristics and determinants: the rotterdam study[J]. Thyroid, 2016, 26(9): 1195-1204.
[14] Mosconi L, Berti V, Quinn C, et al. Perimenopause and emergence of an Alzheimers bioenergetic phenotype in brain and periphery[J]. PLoS One, 2017, 12(10): e0185926. doi:10.1371/journal.pone.0185926.
[15] Hale GE, Robertson DM, Burger HG. The perimenopausal woman: endocrinology and management[J]. J Steroid Biochem Mol Biol, 2014, 142: 121-131. doi:10.1016/j.jsbmb.2013.08.015.
[16] Roberts H, Hickey M. Managing the menopause: an update[J]. Maturitas, 2016, 86: 53-58. doi:10.1016/j.maturitas.2016.01.007.
[17] Palacios S, Castelo-Branco C, Currie H, et al. Update on management of genitourinary syndrome of menopause: a practical guide[J]. Maturitas, 2015, 82(3): 308-313.
[18] Avis NE, Colvin A, Karlamangla AS, et al. Change in sexual functioning over the menopausal transition: results from the Study of Women's Health Across the Nation[J]. Menopause, 2017, 24(4): 379-390.
[19] Baker FC, Lampio L, Saaresranta T, et al. Sleep and sleep disorders in the menopausal transition[J]. Sleep Med Clin, 2018, 13(3): 443-456.
[20] Woodard GA, Brooks MM, Barinas-Mitchell E, et al. Lipids, menopause, and early atherosclerosis in Study of Womens Health Across the Nation Heart women[J]. Menopause, 2011, 18(4): 376-384.
[21] Bjarnason NH, Alexandersen P, Christiansen C. Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent[J]. Bone, 2002, 30(4): 637-642.
[22] Castellani RJ, Rolston RK, Smith MA. Alzheimer disease[J]. Dis Mon, 2010, 56(9): 484-546.
[23] Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics: 2012 update: a report from the American Heart Association[J]. Circulation, 2012, 125(1): 188-197.
[24] Committee on Practice Bulletins—Gynecology. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction[J]. Obstet Gynecol, 2013, 122(1): 176-185.
[25] 中华医学会妇产科学分会妇科内分泌学组. 异常子宫出血诊断与治疗指南[J]. 中华妇产科杂志, 2014, 49(11): 801-806.
[26] 中华医学会妇产科学分会妇科绝经学组. 围绝经期异常子宫出血诊断与治疗专家共识[J].中华妇产科杂志, 2018, 53(6): 396-401.
[27] Reed SD, Lampe JW, Qu CH, et al. Premenopausal vasomotor symptoms in an ethnically diverse population[J]. Menopause, 2014, 21(2): 153-158.
[28] Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition[J]. JAMA Intern Med, 2015, 175(4): 531-539.
[29] Fisher WI, Thurston RC. Measuring hot flash phenomenonology using ambulatory prospective digital diaries[J]. Menopause, 2016, 23(11): 1222-1227.
[30] Sopień R, Wichniak A, Pawlak M, et al. Disturbances of sleep continuity in women during the menopausal transition[J]. Psychiatr Pol, 2015, 49(3): 615-623.
[31] de Zambotti M, Colrain IM, Javitz HS, et al. Magnitude of the impact of hot flashes on sleep in perimenopausal women[J]. Fertil Steril, 2014, 102(6): 1708-1715.e1. doi:10.1016/j.fertnstert.2014.08.016.
[32] Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women[J]. J Gerontol A Biol Sci Med Sci, 2002, 57(12): M772-M777.
[33] van Geel TA, Geusens PP, Winkens B, et al. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study[J]. Eur J Endocrinol, 2009, 160(4): 681-687.
[34] Phillips SK, Rook KM, Siddle NC, et al. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy[J]. Clin Sci, 1993, 84(1): 95-98.
[35] Viña J, Lloret A. Why women have more Alzheimers disease than men: gender and mitochondrial toxicity of amyloid-beta peptide[J]. J Alzheimers Dis, 2010, 20(Suppl 2): S527-S533.
[36] Yao J, Chen SH, Mao ZS, et al. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimers disease[J]. PLoS One, 2011, 6(7): e21788. doi:10.1371/journal.pone.0021788.
[37] Sperling RA, Karlawish J, Johnson KA. Preclinical Alzheimer disease-the challenges ahead[J]. Nat Rev Neurol, 2013, 9(1): 54-58.
[38] Maki PM. Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies[J]. Menopause, 2013, 20(6): 695-709.
[39] Craig MC, Murphy DGM. Estrogen therapy and Alzheimers dementia[J]. Annals of the New York Academy of Sciences, 2010, 1205(1): 245-253.
[1] Benkang SHI,Shouzhen CHEN,Sifeng QU,Yong WANG,Lei LIU. Research progress and clinical characteristics of clinical rapidly progressing prostate cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 110-116.
[2] Yanyan MA,Yaoqin GONG. Application of brain organoids in investigating neurodevelopmental diseases [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 22-29.
[3] Yunfei GUO,Qiang SHU. Role of immunosuppressants in rheumatic disease-associated recurrent spontaneous abortion [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 38-43.
[4] Hongling WEN,Xiaoying XU. Prevention and control of emerging viral infectious diseases and biosafety [J]. Journal of Shandong University (Health Sciences), 2021, 59(5): 40-45.
[5] HAO Wenting, LI Jie, JING Zhengyue, ZHAO Dan, YUAN Yemin, YU Caiting, ZHOU Chengchao. Physical frailty as a mediator between sleep quality and quality of life in rural elderly with chronic diseases in Shandong Province, China [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 102-107.
[6] XU Xiaoming, ZENG Qi, CAO Jun, CHEN Xiaorong, LYU Zhen, WANG Wo, AI Ming, KONG Yiting, KUANG Li. Associations between self-harm behavior and psychosocial-polymorphism in female freshmen [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 84-92.
[7] FU Yilin, GUO Tian, GONG Ying, YAO Zhenyu, GUAN Qingbo, XU Chao, ZHOU Xinli, ZHANG Haiqing, ZHENG Dongmei, LIU Luna, ZHAO Jiajun. Retrospective analysis of causes and clinical characteristics of 554 cases with hypokalemia in endocrinology department: a single-center study [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 39-46.
[8] Chuanzhu YAN,Wei WANG,Kunqian JI,Yuying ZHAO. Mitochondrial dysfunction and related brain diseases [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 34-41.
[9] Xingang LI,Xin ZHANG,Anjing CHEN. The latest advances in human brain projects [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 5-9, 21.
[10] WANG Wei, YANG Yongqin, MI Guolin. Comparison of the efficacy of escitalopram alone and with Qi Yang Yu Xin Dan Fang in the treatment of female depression with sexual dysfunction [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 97-101.
[11] Haotian LIN,Longhui LI,Jingjing CHEN. Research progress of artificial intelligence in childhood eye diseases [J]. Journal of Shandong University (Health Sciences), 2020, 58(11): 11-16.
[12] Yilong YIN,Xiaoming XI. Advances in the intelligent diagnosis of eye diseases [J]. Journal of Shandong University (Health Sciences), 2020, 58(11): 33-38.
[13] Yi QU,Huankai ZHANG,Xian SONG,Baorui CHU. Research progress of artificial intelligence diagnosis system in retinal diseases [J]. Journal of Shandong University (Health Sciences), 2020, 58(11): 39-44.
[14] Cunrui HUANG,Shizhou DENG. Climate change may increase the risk of emerging infectious diseases [J]. Journal of Shandong University (Health Sciences), 2020, 58(10): 7-12.
[15] MA Wei, ZHANG Anran. Impacts of tropical cyclone on human health: latest research progress [J]. Journal of Shandong University (Health Sciences), 2018, 56(8): 29-36.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!